52
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting

, , , , , & show all
Pages 1481-1490 | Published online: 16 Oct 2015

References

  • WHODepression Available from: http://www.who.int/mediacentre/factsheets/fs369/en/Accessed August 13, 2014
  • MurrayCJVosTLozanoRDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592197222323245608
  • RapaportMHClaryCFayyadREndicottJQuality-of-life impairment in depressive and anxiety disordersAm J Psychiatry200516261171117815930066
  • AngermeyerMCHolzingerAMatschingerHStengler-WenzkeKDepression and quality of life: results of a follow-up studyInt J Soc Psychiatry200248318919912413247
  • HirschfeldRMDunnerDLKeitnerGDoes psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationBiol Psychiatry200251212313311822991
  • IshakWWChristensenSSayerGSexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D studyJ Clin Psychiatry201374325626123561231
  • IsHakWWMirochaJJamesDQuality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-upActa Psychiatr Scand20151311516024954156
  • IsHakWWGreenbergJMBalayanKQuality of life: the ultimate outcome measure of interventions in major depressive disorderHarv Rev Psychiatry201119522923921916825
  • Zilcha-ManoSDingerUMcCarthyKSBarrettMSBarberJPChanges in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorderJ Affect Disord2014152–154538542
  • APAPractice Guideline for the Treatment of Patients with Major Depressive Disorder3rd edArlington, VAAmerican Psychiatric Association2010
  • AndersonIMFerrierINBaldwinRCEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelinesJ Psychopharmacol200822434339618413657
  • LamRWKennedySHGrigoriadisSCanadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. PharmacotherapyJ Affect Disord2009117Suppl 1S26S4319674794
  • ThaseMEEntsuahARRudolphRLRemission rates during treatment with venlafaxine or selective serotonin reuptake inhibitorsBr J Psychiatry200117823424111230034
  • PapakostasGIThaseMEFavaMNelsonJCSheltonRCAre antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agentsBiol Psychiatry200762111217122717588546
  • HansenRAGartlehnerGLohrKNGaynesBNCareyTSEfficacy and safety of second-generation antidepressants in the treatment of major depressive disorderAnn Intern Med2005143641542616172440
  • CiprianiAKoestersMFurukawaTADuloxetine versus other anti-depressive agents for depressionCochrane Database Syst Rev201210CD00653323076926
  • ThaseMEPritchettYLOssannaMJSwindleRWXuJDetkeMJEfficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorderJ Clin Psychopharmacol200727667267618004135
  • BairMJRobinsonRLKatonWKroenkeKDepression and pain comorbidity: a literature reviewArch Intern Med2003163202433244514609780
  • ArnowBAHunkelerEMBlaseyCMComorbid depression, chronic pain, and disability in primary carePsychosom Med200668226226816554392
  • BymasterFPLeeTCKnadlerMPDetkeMJIyengarSThe dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depressionCurr Pharm Des200511121475149315892657
  • RobinsonMJSheehanDGaynorPJRelationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetineInt Clin Psychopharmacol201328633033823873291
  • BrechtSCourtecuisseCDebieuvreCEfficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trialJ Clin Psychiatry200768111707171618052564
  • FavaMMallinckrodtCHDetkeMJWatkinJGWohlreichMMThe effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?J Clin Psychiatry200465452153015119915
  • MoultryAMPoonIOThe use of antidepressants for chronic painUS Pharm20093452634
  • SansoneRASansoneLAPain, pain, go away: antidepressants and pain managementPsychiatry (Edgmont)2008512161919724772
  • JungACStaigerTSullivanMThe efficacy of selective serotonin reuptake inhibitors for the management of chronic painJ Gen Intern Med19971263843899192257
  • DuenasHBrnabicAJMLeeATreatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational periodInt J Psychiatry in Clin Pract201115424225422121997
  • DuenasHLeeABrnabicAJMFrequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational studyInt J Psychiatry Clin Pract2011152809022121855
  • WHOThe ICD-10 Classification of Mental and Behavioural Disorders Clinical Descriptions and Diagnostic GuidelinesGeneva, SwitzerlandWorld Health Organization1992
  • APADiagnostic and Statistical Manual of Mental Disorders4th ed text revisionWashington, DCAmerican Psychiatric Publishing2000
  • GuyWECDEU Assessment Manual for Psychopharmacology (Revised)Bethesda, MDUS Department of Health, Education and Welfare1976
  • McGahueyCAGelenbergAJLaukesCAThe Arizona Sexual Experience Scale (ASEX): reliability and validityJ Sex Marital Ther2000261254010693114
  • BerlimMTTureckiGWhat is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trialsEur Neuropsychopharmacol2007171169670717521891
  • BrooksRRabinRde CharroFThe Measurement and Valuation of Health Status using EQ-5D: A European PerspectiveDordrecht, The NetherlandsKluwer Academic Publishers2003
  • RushAJTrivediMHIbrahimHMThe 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiol Psychiatry200354557358312946886
  • KroenkeKSpitzerRLWilliamsJBPhysical symptoms in primary care. Predictors of psychiatric disorders and functional impairmentArch Fam Med1994397747797987511
  • CohenJStatistical Power Analysis for the Behavioral Sciences2nd edHillsdale, NJLawrence Eribaum Associates1988
  • HongJNovickDMontgomeryWReal-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaAsia Pac Psychiatry Epub324201510.1111/appy.12178
  • NovickDHongJMontgomeryWDuenasHGadoMHaroJMPredictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational studyNeuropsychiatr Dis Treat20151119720525653529
  • SzendeAJanssenBCabaseJSelf-Reported Population Health: An International Perspective Based on EQ-5DNew York, NYSpringer Open2014
  • World Health OrganisationWHOQOL. Measuring Quality of LifeGeneva, SwitzerlandWorld Health Organisation1997 Available from: http://www.who.int/mental_health/media/68.pdfAccessed August 24, 2014
  • LangliebAMGuico-PabiaCJBeyond symptomatic improvement: assessing real-world outcomes in patients with major depressive disorderPrim Care Companion J Clin Psychiatry2010122
  • MohiuddinSPayneKUtility values for adults with unipolar depression: systematic review and meta-analysisMed Decis Making201434566668524695961
  • American Psychiatric AssociationPractice guideline for the treatment of patients with major depressive disorder (revision)Am J Psychiatry20001574 Suppl145
  • AngstJSexual problems in healthy and depressed personsInt Clin Psychopharmacol199813Suppl 6S1S49728667
  • BonierbaleMLanconCTignolJThe ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in FranceCurr Med Res Opin200319211412412740155
  • FuAZKattanMWRacial and ethnic differences in preference-based health status measureCurr Med Res Opin200622122439244817257458
  • SapinCFantinoBNowickiMLKindPUsefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderHealth Qual Life Outcomes200422015128456